Abstract
There is increasing concern that the use of second-generation antipsychotic medications in schizophrenia is associated with the development of metabolic syndrome.
| Original language | English (Ireland) |
|---|---|
| Pages (from-to) | 205-210 |
| Number of pages | 6 |
| Journal | Ir J Med Sci |
| Volume | 177 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 1 Sept 2008 |
Keywords
- Atypical antipsychotics
- Clozapine
- Metabolic syndrome
- Physical illness
Authors (Note for portal: view the doc link for the full list of authors)
- Authors
- Ahmed M, Hussain I, O'Brien SM, Dineen B, Griffin D, McDonald C
- Ahmed, M,Hussain, I,O'Brien, SM,Dineen, B,Griffin, D,McDonald, C
Fingerprint
Dive into the research topics of 'Prevalence and associations of the metabolic syndrome among patients prescribed clozapine.'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver